Affiliations 

  • 1 Milton Keynes University Hospital, Standing Way, Eaglestone, Milton Keynes MK6 5LD, UK
  • 2 Leeds Sustainability Institute, Leeds Beckett University, Leeds LS1 3HE, UK
  • 3 Research Centre for Computational Science and Mathematical Modelling, Coventry University, Coventry CV1 5FB, UK
  • 4 Centre for Environment and Agricultural Informatics, Cranfield University, Bedfordshire MK43 0AL, UK
  • 5 Department of Biology, Faculty of Science, University Putra Malaysia, Serdang, Selangor 43400, Malaysia
  • 6 Department of Biostatistics, School of Health, Kermanshah University of Medical Sciences, Kermanshah 6715847141, Iran
  • 7 Faculty of Mathematical Sciences & Statistics, Malayer University, Malayer 6571995863, Iran
PMID: 34207560 DOI: 10.3390/ijerph18126228

Abstract

BACKGROUND: Within the UK, COVID-19 has contributed towards over 103,000 deaths. Although multiple risk factors for COVID-19 have been identified, using this data to improve clinical care has proven challenging. The main aim of this study is to develop a reliable, multivariable predictive model for COVID-19 in-patient outcomes, thus enabling risk-stratification and earlier clinical decision-making.

METHODS: Anonymised data consisting of 44 independent predictor variables from 355 adults diagnosed with COVID-19, at a UK hospital, was manually extracted from electronic patient records for retrospective, case-control analysis. Primary outcomes included inpatient mortality, required ventilatory support, and duration of inpatient treatment. Pulmonary embolism sequala was the only secondary outcome. After balancing data, key variables were feature selected for each outcome using random forests. Predictive models were then learned and constructed using Bayesian networks.

RESULTS: The proposed probabilistic models were able to predict, using feature selected risk factors, the probability of the mentioned outcomes. Overall, our findings demonstrate reliable, multivariable, quantitative predictive models for four outcomes, which utilise readily available clinical information for COVID-19 adult inpatients. Further research is required to externally validate our models and demonstrate their utility as risk stratification and clinical decision-making tools.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.